Company Filing History:
Years Active: 2010-2013
Title: Innovations by Paul J Mintz in Cancer Diagnosis and Therapy
Introduction
Paul J Mintz, an accomplished inventor based in Houston, TX, has made significant contributions to the field of medical innovation. With a focus on cancer research, he holds two patents that showcase his expertise in targeting peptides and gene therapy vectors for enhanced diagnosis and therapeutic applications.
Latest Patents
Mintz's latest patents revolve around compositions and methods of using targeting peptides specifically for the diagnosis and therapy of human cancers, particularly prostate and ovarian cancer. The inventions describe methods for identifying endogenous mimeotopes, such as GRP78, IL-11Rα, and hsp90, which can be utilized in the detection, diagnosis, and staging of these cancers. Furthermore, his innovations include a novel type of gene therapy vector, known as adeno-associated phage (AAP), which is designed for the targeted delivery of therapeutic agents to specific tissues and cell types. His work also extends to targeting peptides that are selective for low-grade lipomas, providing a more effective means of detection and therapy for these conditions.
Career Highlights
Paul J Mintz is affiliated with the University of Texas System, where he continues to develop his groundbreaking ideas in the realm of cancer treatment and diagnosis. His academic and research background has positioned him as a key player in advancing cancer therapeutics through innovative technologies.
Collaborations
Throughout his career, Mintz has collaborated with notable coworkers such as Wadih Arap and Mikhail G Kolonin. These alliances have fostered a collaborative environment that promotes innovation and the cross-pollination of ideas essential for tackling complex medical challenges.
Conclusion
In summary, Paul J Mintz is a significant figure in the landscape of medical innovation, particularly in cancer therapy and diagnosis. His patents reflect a dedication to improving patient outcomes through advanced technologies, cementing his role as a vital contributor to the ongoing fight against cancer.